Average Co-Inventor Count = 4.10
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (22 from 2,074 patents)
2. Ortho-mcneil Pharmaceutical Corp. (22 from 360 patents)
3. Biohaven Therapeutics Ltd. (12 from 28 patents)
4. Mcneil Ab (7 from 188 patents)
5. The Wistar Institute of Anatomy & Biology (7 from 157 patents)
6. Other (4 from 832,575 patents)
7. Rutgers, the State University of New Jersey (4 from 1,451 patents)
8. The Scripps Research Institute (4 from 1,186 patents)
9. Ortho Pharmaceutical Corporation (3 from 377 patents)
10. Oligomerix, Inc. (3 from 10 patents)
11. University of Pennsylvania (2 from 2,568 patents)
12. Musc Foundation for Research Development (2 from 173 patents)
13. Yale University (1 from 1,323 patents)
14. Johnson & Johnson Consumer Companies, Inc. (1 from 271 patents)
15. Janssen Pharmaceuticals, Inc. (159 patents)
101 patents:
1. 12472165 - Riluzole prodrugs and their use
2. 12343347 - Pro-drugs of riluzole and their method of use for the treatment of amyotrophic lateral sclerosis
3. 12331043 - Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use
4. 12295942 - Riluzole prodrugs and their use
5. 12258314 - EBNA1 inhibitors and their method of use
6. 12213965 - Riluzole prodrugs and their use
7. 12172974 - Prodrugs of riluzole and their method of use
8. 12029731 - Acyl benzo[d]thiazol-2-amine and their methods of use
9. 12030868 - Prodrugs of CGRP antagonists
10. 12005046 - Riluzole prodrugs and their use
11. 12005047 - Riluzole prodrugs and their use
12. 11912659 - EBNA1 inhibitors and methods using same
13. 11911369 - Prodrugs of riluzole and their method of use
14. 11731952 - Indene derivatives and uses thereof
15. 11472776 - Quinazolinones that inhibit the formation of tau oligomers and their method of use